Cross Regulatory Cytokine Networks & Rebound Inflammation in Fibrotic Disease
Time: 9:00 am
day: Day One
Details:
- TGFb blockade in fibrotic models results in dysregulation of potentially compensatory inflammatory pathways
- Mixed inflammation is observed in fibrotic indications and preclinical models
- Therapeutic cytokine targeting may require coverage across inflammatory mechanisms to achieve efficacy
